Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shigella4V2 Vaccine Challenge Study in Healthy Volunteers
NCT06615375Phase 2Completed
- Sponsor
- LimmaTech Biologics
- Start
- Nov 2024
- Primary completion
- Apr 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Shigella4V in shigellosis, sponsored by LimmaTech Biologics. Started Nov 2024; status: completed.
02
Drugs
Shigella4V
03
Conditions
shigellosis
Beyond the preview
Go deeper on NCT06615375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06615375.